Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedAug 17, 2026
DataAggregated Company Financials
Companies229
  • 7D6.7%
  • 3M25.0%
  • 1Y15.0%
  • YTD18.0%

In the last week, the Healthcare industry is up 6.7%, with PharmaEssentia up 21%. During this same period, the Center Laboratories underperformed, falling 12%. In the last 12 months, the industry was up 15%. Earnings are forecast to grow by 68% annually.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Aug 2026NT$2.0tNT$287.3bNT$11.6b17.5x174.9x7.1x
Wed, 15 Jul 2026NT$1.9tNT$277.3bNT$17.7b18.6x109.7x7x
Fri, 12 Jun 2026NT$1.6tNT$277.1bNT$17.3b18.8x94.7x5.9x
Sun, 10 May 2026NT$1.6tNT$270.0bNT$17.5b18.5x93x6x
Tue, 07 Apr 2026NT$1.6tNT$270.2bNT$17.7b18.8x89.6x5.9x
Thu, 05 Mar 2026NT$1.7tNT$270.9bNT$19.5b18.2x88x6.3x
Sat, 31 Jan 2026NT$1.9tNT$268.8bNT$12.0b19x156.5x7x
Mon, 29 Dec 2025NT$1.7tNT$267.4bNT$13.6b19x124.5x6.3x
Wed, 26 Nov 2025NT$1.7tNT$267.8bNT$13.1b20x128.6x6.3x
Fri, 24 Oct 2025NT$1.8tNT$266.9bNT$8.2b21.9x216x6.7x
Sun, 21 Sep 2025NT$1.8tNT$266.0bNT$8.2b22.4x215.9x6.7x
Tue, 19 Aug 2025NT$1.7tNT$266.3bNT$9.2b21.5x184.1x6.4x
Thu, 17 Jul 2025NT$1.6tNT$261.0bNT$16.4b20.1x97.7x6.1x
Sat, 14 Jun 2025NT$1.6tNT$260.9bNT$16.3b19.9x95.4x6x
Mon, 12 May 2025NT$1.4tNT$258.0bNT$13.1b20.5x110.5x5.6x
Wed, 09 Apr 2025NT$1.3tNT$254.3bNT$12.0b18.6x107.6x5.1x
Fri, 07 Mar 2025NT$1.6tNT$249.8bNT$11.3b23.7x144.7x6.6x
Sun, 02 Feb 2025NT$1.5tNT$246.2bNT$8.7b22.2x176.1x6.3x
Tue, 31 Dec 2024NT$1.5tNT$245.2bNT$8.6b22.4x173.2x6.1x
Thu, 28 Nov 2024NT$1.5tNT$244.9bNT$9.1b22x165.6x6.1x
Sat, 26 Oct 2024NT$1.6tNT$236.7bNT$6.9b25.7x225.4x6.6x
Mon, 23 Sep 2024NT$1.6tNT$236.4bNT$6.8b24.6x236.9x6.8x
Wed, 21 Aug 2024NT$1.6tNT$236.7bNT$6.8b26x237.8x6.9x
Fri, 19 Jul 2024NT$1.7tNT$229.1bNT$3.7b30x454.8x7.4x
Sun, 16 Jun 2024NT$1.5tNT$228.6bNT$3.9b26.4x392x6.7x
Tue, 14 May 2024NT$1.4tNT$229.3bNT$4.6b26x314.5x6.3x
Thu, 11 Apr 2024NT$1.6tNT$228.5bNT$5.0b27.7x311x6.9x
Sat, 09 Mar 2024NT$1.4tNT$226.2bNT$7.0b25.2x205.8x6.3x
Mon, 05 Feb 2024NT$1.4tNT$225.3bNT$6.1b24.6x228.2x6.2x
Wed, 03 Jan 2024NT$1.4tNT$224.9bNT$6.0b25.4x235.5x6.3x
Fri, 01 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.4x241.1x6.3x
Sun, 29 Oct 2023NT$1.4tNT$225.3bNT$8.3b25.3x166.2x6.1x
Tue, 26 Sep 2023NT$1.4tNT$225.2bNT$8.2b25.8x168.2x6.1x
Thu, 24 Aug 2023NT$1.4tNT$225.2bNT$8.4b24.5x161.7x6x
Price to Earnings Ratio

161.7x


Total Market Cap: NT$1.4tTotal Earnings: NT$8.4bTotal Revenue: NT$225.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 187.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 175x which is lower than its 3-year average PE of 188x.
  • The 3-year average PS ratio of 6.4x is lower than the industry's current PS ratio of 7.1x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 12% per year over the last three years.
  • Revenues for these companies have grown 8.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market3.58%
Healthcare6.75%
Biotech14.52%
Life Sciences1.99%
Medical Equipment0.89%
Healthcare Services-0.013%
Pharma-2.04%
Healthtech-5.59%
Industry PE
  • Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 61.0x.
    • Analysts are expecting annual earnings growth of 95.1%, which is higher than its past year's earnings growth of 9.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 115% over the next 5 years.
  • This is better than its past earnings decline of 3.4% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 51% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6446 PharmaEssentiaNT$1.41k6.0%
+NT$36.1b		246.4%PE76.6x
6696 Lin BioScienceNT$947.0031.5%
+NT$18.8b		499.4%PB7.3x
6949 Pell Bio-Med TechnologyNT$1.06k11.3%
+NT$6.9b		209.4%PS2363x
4736 TaiDoc TechnologyNT$143.009.6%
+NT$1.2b		1.4%PE7.8x
6467 Taho PharmaceuticalsNT$136.0016.7%
+NT$1.0b		1.9%PS1313.9x

Latest News

6949
NT$1,055.00
Pell Bio-Med Technology
7D
11.3%
1Y
209.4%
1795
NT$183.50
Lotus Pharmaceutical
7D
-5.2%
1Y
-5.4%
4123
NT$32.67
Center Laboratories
7D
-12.3%
1Y
-4.2%
7871
NT$115.00
Elixiron Immunotherapeutics (Cayman)
7D
37.2%
1Y
n/a
4736
NT$143.00
TaiDoc Technology
7D
9.6%
1Y
1.4%
6446
NT$1,410.00
PharmaEssentia
7D
6.0%
1Y
246.4%
6472
NT$416.00
Bora Pharmaceuticals
7D
-3.5%
1Y
-46.5%
Narrative Update • Aug 13

6472: Future Alliance Framework Will Support Long-Term Upside Potential

The analyst price target for Bora Pharmaceuticals has been revised from NT$1,060 to NT$729.29, with analysts citing adjusted fair value, discount rate assumptions and expectations for revenue growth, profit margin and future P/E as key drivers of the change. What's in the News for Bora Pharmaceuticals InSilico Medicine Cayman TopCo entered into a multi-target alliance framework with Bora Pharmaceuticals, focused on drug discovery and development.
6919
NT$102.50
Caliway Biopharmaceuticals
7D
-7.7%
1Y
-35.7%
6491
NT$363.50
Pegavision
7D
-4.1%
1Y
14.5%
7799
NT$350.00
Heron Neutron Medical
7D
-2.2%
1Y
-59.0%
6696
NT$912.00
Lin BioScience
7D
26.7%
1Y
477.2%
6617
NT$101.00
Gongwin Biopharm Holdings
7D
4.9%
1Y
-1.0%
6499
NT$66.80
Medeon Biodesign
7D
16.2%
1Y
-35.5%
7924
NT$240.00
TLC BioSciences
7D
4.3%
1Y
n/a
6748
NT$175.00
ACRO Biomedical
7D
-10.3%
1Y
134.3%
6586
NT$113.00
CHO Pharma
7D
-5.4%
1Y
202.9%